Tag

Fundraising / Financing

6 articles
Indian companies are actively pursuing diverse fundraising strategies to fuel growth and manage debt. Several firms, including Blue Jet Healthcare, Vertoz Limited, and Sudarshan Pharma, have recently secured shareholder or board approvals for fundraising initiatives, potentially utilizing equity or debt instruments. Tata Communications bolstered its short-term funding with a ₹400 crore commercial paper issuance, while Grovy India secured shareholder approval for a preferential issue of ₹15.01 crore to repay loans and support project development, alongside a dividend declaration. This broad activity signals a continued focus on capital deployment and strategic expansion within the Indian corporate sector, though investors should monitor the specifics of each transaction and potential dilution effects.
Royal Sense Board Approves ₹500 Crore Fundraising, Capital Hike
Board approved increasing authorized share capital from ₹10 Cr to ₹20 Cr, subject to shareholder approval in the upcoming AGM. Approved raising up to ₹500 Crores via various debt instruments including
Standard Engineering EGM Approves ₹136.48 Cr Preferential Issue
• EGM on Aug 10, 2026 to approve preferential issue of 46.58 lakh shares raising ₹136.48 crore to AGI Group and Monoflus Pte Ltd. • Share swap acquisition of 17.45% in GScale Energy for 22.18 lakh sha
Sancode Technologies Allots ₹40 Cr Convertible Warrants
Sancode Technologies board approved preferential allotment of 23.26 lakh convertible warrants at ₹172 each, raising ₹40 crore. Allottees include promoter Khushboo Jain and two non-promoter entities, A
Mahan Industries Board Approves ₹29.82 Crore Preferential Fundraise
Board approved preferential issue of 32 lakh equity shares at ₹12 each to raise ₹3.84 crore, triggering an open offer and change in control. Approved issuance of 2.16 crore convertible warrants at ₹12
Ather Energy Preferential Issue Pricing Details
Ather Energy discloses pricing details for its approved preferential issue of equity shares and convertible warrants. Equity shares priced at INR 1,230 each to India-Japan Fund, INR 54.26 above the IN
Swastika Investmart Board to Consider Fundraising
Swastika Investmart's Board will meet on July 20, 2026, to approve unaudited Q1 FY27 results and evaluate a fundraising proposal. The fundraising may involve equity shares, convertible securities, war